Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
RemedyBio Completes €10.5M Financing from European Innovation Council
RemedyBio, an immunology focused discovery and development company, today announces the final closing of an […]
Fully Vaccinated Critical Workers to be Able to Leave Self-isolation in Exceptional Circumstances
Railway signallers and air traffic controllers are among the critical workers who may in exceptional […]
AI Startup Lunit Secures Investment from Guardant Health in a Strategic Funding Round
Lunit, a leading AI startup in AI-powered cancer solutions, today announced a strategic investment of […]
TGen Looks Beyond COVID-19 as it Advances Pathogen Sequencing
Amidst the darkness of the pandemic, a shining light from the COVID-19 response is the […]
PEP-Therapy Extends Series-A Financing, Raising a Total of €5.4 Million to Progress the Clinical Development of its Lead Candidate PEP-010
PEP-Therapy, a biotechnology company developing cell penetrating peptides as targeted therapies for the treatment of […]
New Data for Roche’s Hemlibra Reinforce Safety Profile in People with Haemophilia A
Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced results from the final analysis of the […]
UK to Roll Out Biggest Flu Programme in History for Winter 2021
Millions more people could benefit from a free flu vaccine this year, as the Health […]
Almost 100% of People Have Antibodies After Second Vaccine
Imperial College London and Ipsos MORI have today published their latest antibody surveillance report showing, […]
New COVID-19 Saliva Test Makes Testing Far Easier for All Ages
UK company Intelligent Fingerprinting, manufacturers of the world’s first and only fingerprint sweat drug test, has […]
Rising Demand for Needle-free Vaccines to Drive Innovation in the Respiratory Virus Vaccines Market
A vaccination refers to a biological product that is utilized to provide acquired immunity against a […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more